3 Health Care Stocks Under $10 to Watch: MannKind and More

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Must Read: 10 Stocks Billionaire John Paulson Loves 

Geron

Geron (GERN - Get Report) , a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. This stock is trading up 2% to $3.39 in Tuesday's trading session.

Tuesday's Range: $3.28-$3.44 
52-Week Range: $1.31-$5.24 
Tuesday's Volume: 749,000 
Three-Month Average Volume: 5.14 million

From a technical perspective, GERN is spiking modestly higher here right off its 50-day moving average of $3.29 with lighter-than-average volume. This stock has been uptrending over the last month and change, with shares moving higher from its low of $2.91 to its recent high of $3.53. During that uptrend, shares of GERN have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GERN within range of triggering a near-term breakout trade. That trade will hit if GERN manages to take out some key near-term overhead resistance at $3.53 with high volume.

Traders should now look for long-biased trades in GERN as long as it's trending above some key near-term support levels at $3.15 or at $3.08 and then once it sustains a move or close above $3.53 with volume that hits near or above 5.14 million shares. If that breakout hits soon, then GERN will set up to re-test or possibly take out its next major overhead resistance levels at $3.96 to $4.50.

Must Read: 11 Stocks Warren Buffett Loves 

MannKind

MannKind (MNKD) , a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the U.S. This stock is trading up 2.9% to $6.25 in Tuesday's trading session.

Tuesday's Range: $6.00-$6.34 
52-Week Range: $3.80-$11.48 
Tuesday's Volume: 2.49 million 
Three-Month Average Volume: 4.25 million

From a technical perspective, MNKD is counter-trending higher here versus the overall market weakness with decent upside volume flows. This stock recently formed a triple bottom chart pattern, after buyers came in to support the price at $4.96, $5.14 and $5.21. Following that bottom, shares of MNKD have started to spike higher back above its 50-day moving average and into breakout territory above some near-term overhead resistance at $5.94. That move his now quickly pushing shares of MNKD within range of triggering another near-term breakout trade. That trade will hit if MNKD manages to clear some key near-term overhead resistance levels at $6.65 to its 200-day moving average of $7.06 with high volume.

Traders should now look for long-biased trades in MNKD as long as it’s trending above its 50-day moving average of $5.67 and then once it takes out those breakout levels with volume that hits near or above 4.25 million shares. If that breakout begins soon, then MNKD will set up to re-test or possibly take out its next major overhead resistance levels at $7.50 to $7.64, or even $8 to $8.50.

Must Read: 10 Stocks George Soros Is Buying

Hansen Medical

Hansen Medical (HNSN - Get Report) develops, manufactures and sells medical robotics designed for the positioning, manipulation and control of catheters and catheter-based technologies. This stock is trading up 8.7% to 62 cents per share in Tuesday's trading session.

Tuesday's Range: $0.58-$0.62 
52-Week Range: $0.52-$2.89 
Tuesday's Volume: 266,000 
Three-Month Average Volume: 299,226

From a technical perspective, HNSN is counter-trending versus the overall market weakness and ripping sharply higher here right above some near-term support at 57 cents per share with strong upside volume flows. This spike to the upside on Tuesday is now quickly pushing shares of HNSN within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will hit if HNSN manages to take out some near-term overhead resistance levels at its 63 cents to 64 cents per share and then above its 50-day moving average of 67 cents per share with high volume.

Traders should now look for long-biased trades in HNSN as long as it's trending above some key near-term support at 57 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 299,226 shares. If that breakout develops soon, then HNSN will set up to re-test or possibly take out its next major overhead resistance levels at 72 cents to 75 cents per share, or even 80 cents to 85 cents per share.

-- Written by Roberto Pedone in Delafield, Wis.

Source:http://www.thestreet.com